Research and education form the backbone
of our work in digital pathology.
Qritive proud to be named the inaugural recipient of Johnson & Johnson Innovation – JLABS Singapore
Singapore is home to more than 30 corporate R&D centres for biomedical sciences and 100 locally incorporated biotechs as of 2020. Now, with the launch of JLABS Singapore, the b
Qritive at 35th European Congress of Pathology
Qritive presenting its poster titled “A deep learning based tool for histological detection of malignancy in prostate core needle biopsies”, at ECP Dublin 2023.
AI for Prostate Histopathology: A Pilot Study
Dr Lau Hiu Yeung (Resident, Singhealth Pathology Residency Programme) giving his presentation “AI for Prostate Histopathology: A Pilot Study”, a collaboration with Qritive.
Assessing the Ability of AI To Score Ki-67 in Sarcomas
Quantitative immunohistochemistry (IHC) is an integral part of histopathology reporting, providing vital information such as tumour characterisation and prognosis. Ki-67 proliferat
Qritive Launches QAi Prostate: Advanced AI-Powered Prostate Cancer Diagnosis Tool for Pathologists
Qritive, a leading provider of digital pathology solutions, announced the launch of a new AI (Artificial Intelligence) module, QAi Prostate, for prostate cancer diagnosis. Using ad
Qritive and Corista Announce Partnership to Advance the Use of Computational Digital Pathology Workflows with Integrated Image Management
Corista, a leading provider of clinical, research and educational digital pathology image management solutions, and Qritive, a leading developer of artificial intelligence (AI)-pow